1.
Aliment Pharmacol Ther
; 59(10): 1284-1285, 2024 May.
Article
En
| MEDLINE
| ID: mdl-38652777
Liver Cirrhosis , Terlipressin , Vasoconstrictor Agents , Humans , Terlipressin/therapeutic use , Liver Cirrhosis/drug therapy , Liver Cirrhosis/complications , Vasoconstrictor Agents/adverse effects , Vasoconstrictor Agents/therapeutic use , Lypressin/analogs & derivatives , Lypressin/therapeutic use , Lypressin/adverse effects